These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 38280106

  • 1. Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations.
    Yu L, Xu Z, Wei L, Zhang B, Qiu L, Ma L, Li L.
    Paediatr Drugs; 2024 May; 26(3):309-317. PubMed ID: 38280106
    [Abstract] [Full Text] [Related]

  • 2. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
    Czechowicz JA, Long-Boyle JR, Rosbe KW, Mathes EF, Frieden IJ, Shimano KA.
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
    [Abstract] [Full Text] [Related]

  • 3. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J, Seront E, Duez S, Dupont S, Van Damme A, Schmitz S, Hoyoux C, Chopinet C, Clapuyt P, Hammer F, Vikkula M, Boon LM.
    Orphanet J Rare Dis; 2018 Oct 29; 13(1):191. PubMed ID: 30373605
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S.
    Pediatr Dermatol; 2020 Mar 29; 37(2):272-277. PubMed ID: 31957126
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies.
    Grenier PO, McCormack L, Alshamekh SA, Adams DM, Trenor CC, O'Hare MJ, Liang MG.
    JAMA Dermatol; 2021 Feb 01; 157(2):233-235. PubMed ID: 33404600
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of oral sirolimus for high-flow vascular malformations in real clinical practice.
    Durán-Romero AJ, Hernández-Rodríguez JC, Ortiz-Álvarez J, Domínguez-Cruz JJ, Monserrat-García MT, Conejo-Mir Sánchez J, Bernabeu-Wittel J.
    Clin Exp Dermatol; 2022 Jan 01; 47(1):57-62. PubMed ID: 34240451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl.
    Cardis MA, DeKlotz CMC.
    Pediatr Dermatol; 2018 Nov 01; 35(6):e406-e407. PubMed ID: 30152558
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B.
    JAMA Dermatol; 2021 Nov 01; 157(11):1289-1298. PubMed ID: 34524406
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Single-center experience with sirolimus therapy for vascular malformations.
    Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G.
    Pediatr Hematol Oncol; 2016 Apr 01; 33(3):219-25. PubMed ID: 27128161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.